Positive Results in Trial for New Asthma Treatment

Synairgen, a drug development company that spun out of the University of Southampton, United Kingdom, has announced positive results of a phase 2 clinical trial of its asthma drug SNG001...

Read full article: rtmagazine.com



Allergy and asthma diagnosis for Astana’s Kessiakoff

Astana’s Fredrik Kessiakoff has revealed the likely reason for his drop in form of recent weeks, saying that tests have shown that his body has been under attack...

Read full article: velonation.com



SkyePharma soars on asthma drug approval

SkyePharma has been hurt by concerns over its asthma therapy, Flutiform, with the share price taking a tumble just before Christmas as traders learnt of another delay to its European approval...

Read full article: telegraph.co.uk